Home > BIGG > Search result

    Results: 24

    Guía de práctica clínica para el manejo inicial de leucemia linfoblástica aguda

    Peru. Instituto de Evaluación de Tecnologías en Salud e Investigación.
    La Leucemia linfoblástica aguda (LLA) es una neoplasia hematológica maligna caracterizada por el aumento de linfoblastos en la sangre y la médula ósea, siendo considerada la neoplasia más frecuente en la población infantil (1). A nivel mundial, se estima que la incidencia de LLA oscila entre uno a ...
    Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Antineoplastic Agents/therapeutic use
    Fulltext

    European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

    Raverot, G; Burman, P; McCormack, A; Heaney, A; Petersenn, S; Popovic, V; Trouillas, J; Dekkers, O. M.
    Eur. j. endocrinol; 178 (1), 2018
    BACKGROUND: Pituitary tumours are common and easily treated by surgery or medical treatment in most cases. However, a small subset of pituitary tumours does not respond to standard medical treatment and presents with multiple local recurrences (aggressive pituitary tumours) and in rare occasion with meta...
    Pituitary Neoplasms/therapy, Carcinoma/therapy, Antineoplastic Agents/therapeutic use
    Fulltext

    Guía de práctica médica leucemia crónica en personas de 15 años y más

    Chile. Ministerio de Salud. Gobierno de Chile.
    Generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo de personas de 15 años y más con Leucemia crónica. Personas de 15 años y más con Leucemia crónica que reciben atención en el nivel secundario y terciario de salud en el sector público y privado de salud....
    Leukemia, Myeloid/prevention & control, Leukemia, Myeloid/diagnosis, Leukemia, Myeloid/drug therapy, Risk Factors, Antineoplastic Agents/therapeutic use, Antineoplastic Agents, Alkylating/therapeutic use
    Fulltext

    Advanced breast cancer: diagnosis and treatment. Last updated: 2017

    England. National Institute for Health and Care Excellence.
    This guideline covers care and support for people with advanced (stage 4) breast cancer. It aims to help them and their healthcare professionals make shared decisions about tests and treatments to improve outcomes and quality of life. A table of NHS England interim treatment regimens gives possible alter...
    Inflammatory Breast Neoplasms/diagnosis, Breast Neoplasms/drug therapy, Antineoplastic Agents/therapeutic use, Trastuzumab/therapeutic use, Quality of Life
    Fulltext

    Guía de práctica clínica para el diagnóstico y tratamiento de cáncer de mama her 2 positivo no metastásico

    Peru. EsSalud. Instituto de Evaluación de Tecnologías en Salud e Investigación.
    Este documentoabarca a las pacientes con cáncer de mama HER 2 positivo no metastásico. La Guía se enfoca en el proceso diagnóstico y tratamiento sistémico del cáncer de mama HER 2 positivo no metastásico con receptores hormonales negativos....
    Breast Neoplasms/diagnosis, Breast Neoplasms/drug therapy, Genes, erbB-2, Immunohistochemistry/methods, In Situ Hybridization/methods, Trastuzumab/therapeutic use, Anthracyclines/therapeutic use, Neoadjuvant Therapy/methods, Antineoplastic Agents/administration & dosage
    Fulltext

    Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

    Dent, S; Brezden-Masley, C; Clarke, B; Davis, MK; Jassal, DS; Johnson, C; Lemieux, J; Paterson, I; Sebag, IA; Simmons, C; Sulpher, J; Thain, K; Thavendiranathan, P; Wentzell, JR; Wurtele, N; Côté, MA; Fine, NM; Haddad, H; Hayley, BD; Hopkins, S; Joy, AA; Rayson, D; Stadnick, E; Straatman, L; Virani, SA.
    Can. j. cardiol; 32 (7), 2016
    Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
    Antineoplastic Agents, Biomarkers, Cardiotonic Agents, Cardiotoxins, Troponin T, Natriuretic Peptide, Brain, C-Reactive Protein, Antineoplastic Agents/adverse effects, Arrhythmias, Cardiac, Cardiotoxicity, Coronary Thrombosis, Early Diagnosis, Echocardiography, Three-Dimensional, Hypertension/therapy, Magnetic Resonance Imaging, Cine, Myocardial Ischemia, Neoplasms/therapy, Primary Prevention, Radiotherapy, Risk Factors, Ventricular Dysfunction, Left, Cardiotoxicity/diagnosis, Cardiotoxins/adverse effects, Radiotherapy/adverse effects
    Fulltext

    Haematological cancers: improving outcomes

    England. National Institute for Health and Care Excellence.
    This guideline covers integrated diagnostic reporting for diagnosing haematological cancer in adults, young people and children. It also covers staffing, facilities (levels of care) and multidisciplinary teams needed for adults and young people. It aims to improve care for people with suspected or diagno...
    Hematologic Neoplasms/prevention & control, Hematologic Neoplasms/diagnosis, Antineoplastic Agents/therapeutic use, Outpatient Clinics, Hospital/organization & administration, Patient Care Team, Oncology Service, Hospital/organization & administration
    Fulltext

    Guía GEICAM de práctica clínica para el diagnóstico y tratamiento del cáncer de mama metastásico

    (Grupo Español de Investigación en Cáncer de Mama.
    El objetivo principal de esta Guía es recoger recomendaciones para el diagnóstico y el tratamiento de mujeres con cáncer de mama metastásico....
    Breast Neoplasms/diagnosis, Breast Neoplasms/therapy, Neoplasm Metastasis, Trastuzumab/therapeutic use, Tamoxifen/therapeutic use, Goserelin/therapeutic use, Aromatase Inhibitors/therapeutic use, Everolimus/therapeutic use, Positron-Emission Tomography/methods, Positron Emission Tomography Computed Tomography/methods, Bone Neoplasms/secondary, Biopsy, GRADE Approach, Antineoplastic Agents/administration & dosage
    Fulltext

    Guía de práctica clínica (GPC): guía de GELTAMO para diagnóstico, prevención y manejo terapéutico de la afectación del sistema nervioso central en pacientes con linfoma b difuso de célula grande

    Javier Peñalver, Francisco; Fuente, Adolfo de la; Olave, Teresa; Orfao, Alberto; Sancho, Juan Manuel.
    El objetivo principal de la guía es proporcionar a los profesionales sanitarios, recomendaciones para la prevención, el diagnóstico y el manejo terapéutico de los pacientes con Linfoma B Difuso de célula grande (LBDCG), que presentan (o tienen riesgo de) afectación leptomeníngea o del parénquima ...
    Lymphoma, Large B-Cell, Diffuse/drug therapy, Lymphoma, Large B-Cell, Diffuse/diagnosis, Central Nervous System Diseases/etiology, Spinal Puncture/methods, Biopsy/methods, Magnetic Resonance Spectroscopy/methods, Methotrexate/therapeutic use, Rituximab/therapeutic use, Antineoplastic Agents/therapeutic use, GRADE Approach, Central Nervous System Diseases/prevention & control
    Fulltext